Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization

Biochemical and Biophysical Research Communications

Volumn 332, Issue 1, 2005, Pages 194-199

  Singh, Nirbhai ^a   Macnamara, Elizabeth ^a   Rashid, Saadia ^a   Ambati, Jayakrishna ^b   Kontos, Christopher D ^c   Higgins, Eric ^a   Ambati, Balamurali K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Angiopoietin; Cornea; Inhibition; Neovascularization; Regression; Tie2

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORNEA INJURY; CORNEA NEOVASCULARIZATION; DRUG EFFECT; DRUG MECHANISM; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; CORNEAL NEOVASCULARIZATION; MEN; MICE; MICE, INBRED BALB C; RECEPTOR, TIE-2; SOLUBILITY; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENOVIRIDAE;

EID: 19344365737     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.108     Document Type: Article

References (73)

1. B. Millauer, M.P. Longhi, and K.H. Plate Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo Cancer Res. 56 1996 1615 1620
2. C.K. Goldman, R.L. Kendall, and G. Cabrera Paracrine expression of a native soluble vascular endothelium growth factor receptor inhibits tumor growth, metastasis, and mortality rate Proc. Natl. Acad. Sci. USA 95 1998 8795 8800
3. M. Prewett, J. Huber, and Y. Li Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors Cancer Res. 59 1999 5209 5218
4. N. Ferrara Vascular endothelial growth factor: molecular and biological aspects Curr. Top. Microbiol. Immunol. 237 1999 1 30
5. V. Brower Tumor angiogenesis-new drugs on the block Nat. Biotechnol. 17 1999 963 968
6. H. Takagi, S. Koyama, and H. Seike Potential role of the angiopoietin/Tie2 system in ischemia-induced retinal neovascularization Invest. Ophthalmol. Vis. Sci. 44 2003 393 402
7. T.N. Sato, Y. Tozawa, and U. Deutsch Distinct role of the receptor tyrosine kinases Tie1 and Tie2 in blood vessel formation Nature 376 1995 70 74
8. C. Suri, P.F. Jones, and S. Patan Requisite role of angiopoietin-1, a ligand for the Tie2, during embryonic angiogenesis Cell 87 1996 1171 1180
9. S. Davis, T.H. Aldrich, and P.F. Jones Isolation of angiopoietin-1, a ligand for Tie2, by secretion-trap expression cloning Cell 87 1996 1161 1169
10. A.L. Wong, Z.A. Haroon, and S. Werner Tie2 expression and phosphorylation in angiogenic and quiescent tissues Circ. Res. 8 1997 567 574
11. T. Asahara, D. Chen, and T. Takahashi Ang1 and Ang2 modulate VEGF-induced postnatal neovascularisation Circ. Res. 83 1998 233 240
12. A. Otani, H. Takagi, and H. Oh Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes Invest. Ophthalmol. Vis. Sci. 40 1999 1912 1920
13. P. Lin, J.A. Buxton, and A. Acheson Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2 Proc. Natl. Acad. Sci. USA 95 1998 8829 8834
14. P.C. Maisonpierre, C. Suri, and P.F. Jones Ang2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 1997 55 60
15. H. Oh, H. Takagi, and K. Suzuma Hypoxia and VEGF selectively upregulate ang2 in bovine microvascular endothelial cells J. Biol. Chem. 274 1999 15732 15739
16. S. Tanaka, M. Mori, and Y. Sakamoto Biological significance of ang2 in human hepatocellular carcinoma J. Clin. Inv. 103 1999 341 345
17. J. Holash, P.C. Maisonpierre, and D. Compton Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 284 1999 1994 1998
18. S.J. Mandriota, and M.S. Pepper Regulation of ang2 mRNA in BMEC by cytokines and hypoxia Circ. Res. 83 1998 852 859
19. D.J. Dumont, G. Gradwhol, and G.H. Fong Dominant-negative and targeted null mutations in the endothelial receptor tyrosine-kinase, tek, reveal a critical role in vasculogenesis of the embryo Genes Dev. 9 1994 1897 1909
20. G. Thurston, J.S. Rudge, and E. Ioffe Angiopoietin-1 protects the adult vasculature against plasma leakage Nat. Med. 6 2000 460 463
21. K.J. Kim, B. Li, and J. Winer Inhibition of VEGF-induced angiogenesis suppresses tumor growth in vivo Nature 362 1993 841 844
22. B. Millauer, L.K. Shawver, and K.H. Plate Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature 367 1994 576 579
23. H.F. Dvorak, J.A. Nagy, and D. Feng Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis Curr. Top. Microbiol. Immunol. 237 1999 97 132
24. P. Carmeliet, and D. Collen Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development Curr. Top. Microbiol. Immunol. 237 1999 133 158
25. S. Amano, R. Rohan, and M. Kuroki Requirement for VEGF in wound- and inflammation-induced neovascularization Invest. Ophthalmol. Vis. Sci. 39 1998 18 22
26. T. Alon, I. Hemo, and A. Itin Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity Nat. Med. 1 1995 1024 1028
27. P. Lin, P. Polverini, and M. Dewhirst Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth J. Clin. Invest. 100 1997 2072 2078
28. G. Siemeister, M. Schirner, and K. Weindel Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway Cancer Res. 59 1999 3185 3191
29. K.G. Peters, A. Coogan, and D. Berry Expression of Tie2 in breast tumour vasculature provides a new marker for evaluation of tumor angiogenesis Br. J. Cancer 77 1998 51 56
30. M. Hangai, Y.S. Moon, and N. Kitaya Systemically expressed soluble Tie2 inhibits intraocular neovascularization Hum. Gene Ther. 12 2001 1311 1321
31. R.R. White, S. Shan, and C.P. Rusconi Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 Proc. Natl. Acad. Sci. USA 100 2003 5028 5033
32. I.B. Lobov, P.C. Brooks, and R.A. Lang Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo Proc. Natl. Acad. Sci. USA 99 2002 11205 11210
33. R.R. Ali, M.B. Reichel, and M. De Alwis Adeno-associated virus gene transfer to mouse retina Hum. Gene Ther. 9 1998 81 86
34. F. Rolling, W.Y. Shen, and H. Tabarias Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography Hum. Gene Ther. 10 1999 641 648
35. L. Dudus, V. Anand, and G.M. Acland Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV Vis. Res. 38 1999 2545 2553
36. J. Bennett, D. Duan, and J.F. Engelhardt Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction Invest. Ophthalmol. Vis. Sci. 38 1997 2857 2963
37. J.G. Flannery, S. Zolotukhin, and M.I. Vaquero Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus Proc. Natl. Acad. Sci. USA 94 1997 6916 6921
38. B.K. Ambati, A.M. Joussen, and A. Anand Angiostatin inhibits and regresses corneal neovascularization Arch. Ophthalmol. 120 2002 1063 1068
39. A.D. Proia, D.B. Chandler, and W.L. Haynes Quantitation of corneal neovascularization using computerized image analysis Lab. Invest. 58 1988 473 479
40. M. Saito, M. Hamasaki, and M. Shibuya Induction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF Cancer Sci. 94 2003 782 790
41. H.J. Kaplan, M.A. Leibole, and T. Tezel FasL controls angiogenesis beneath the retina Nat. Med. 5 1999 292 297
42. B.C. Richardson, N.D. Lalwani, and K.J. Johnson Fas ligation triggers apoptosis in macrophages Eur. J. Immunol. 23 1994 2640 2645
43. C.D. Kontos, T.P. Stauffer, and W.P. Yang Tyrosine 1101 of Tie 2 is major site of association of p85 and is required for activation of Pi3-kinase and akt Mol. Cell. Biol. 18 1998 4131 4140
44. G. Kulik, A. Kilippel, and M.J. Weber Antiapoptic signaling by IGF-1 receptor, PI3- kinase, and AKT Mol. Cell. Biol. 17 1997 1595 1606
45. S.R. Datta, H. Dudek, and X. Tao Akt phosphorylation of BAD couples survival signals to cell-intrinsic death machinery Cell 91 1997 231 241
46. L. Del Peso, M. Gonzalez-Garcia, and C. Page IL-3 induced phosphorylation of BAD through the protein kinase Akt Science 278 1997 687 689
47. C.L. Hu, R.G. Cowan, and R.M. Harman Cell cycle progression and activation of Akt are required for IGF-1 mediated suppression of apoptosis in granulose cells Mol. Endocrinol. 18 2004 326 338
48. H. Schulze-Bergkamen, D. Brenner, and A. Krueger Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt Hepatology 39 2004 645 654
49. M.R. Abid, S. Guo, and T. Minami VEGF activates PI3K/Akt signaling in endothelial cells Arterioscler. Thromb. Vasc. Biol. 24 2004 294 300
50. D.J. Panka, and J.W. Mier Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells J. Biol. Chem. 278 2003 37632 37636
51. J.M. Wigginton, E. Gruys, and L. Geiselhart IFN-gamma and Fas/FasL are required for antitumor and antiangiogenic effects of IL-12 J. Clin. Invest. 108 2001 51 62
52. P.M. Stuart, F. Pan, and S. Plambeck Fas-FasL regulate NV in cornea Invest. Ophthalmol. Vis. Sci. 44 2003 93 98
53. Y.H. Chen, H.L. Wu, and C.K. Chen Angiostatin antagonizes VEGF-a IN human endothelial cells via 2 distinct pathways Biochem. Biophys. Res. Commun. 310 2003 804 810
54. M.H. Davies, J.P. Eubanks, and M.R. Powers Increased retinal neovascularization in Fas ligand-deficient mice Invest. Ophthalmol. Vis. Sci. 44 2003 3202 3210
55. Y. Takemura, K. Fukuo, and O. Yasuda Fas signaling induces Akt activation and upregulation of eNOS expression Hypertension 2004 Epub ahead of print
56. M. Osaki, S. Kase, and K. Adachi Inhibition of PI3K-Akt signaling pathway enhances sensitivity of Fas mediated apoptosis in human gastric carcinoma J. Cancer Res. Clin. Oncol. 130 2004 8 14
57. R.G. Jones, A.R. Elford, and M.J. Parsons CD28-dependent activation of Akt blocks Fas-mediated apoptosis by preventing DISC assembly J. Exp. Med. 196 2002 335 348
58. E. Hatano, and D.A. Brenner Akt protects mouse hepatocytes from TNF and Fas- mediated apoptosis through NFkB activation Am. J. Physiol. Gastrointest. Liver Physiol. 281 2001 1357 1368
59. T. Suhara, T. Mano, and B.E. Oliveira PI3k/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis Circ. Res. 89 2001 13 19
60. P. Kuenzi, P. Schneider, and D.A. Dobbelaere Theileria parva-transformed T cells show enhanced resistance to Fas/FasL induced apoptosis J. Immunol. 171 2003 1224 1231
61. M.A. Moore, K. Hattori, and B. Heissing Mobilization of endothelial progenitor cells by adenovector-mediated elevation of serum SDF-1, VEGF, and angiopoietin-1 Ann. N.Y. Acad. Sci. 938 2001 36 45
62. F. Mirshahi, J. Pourtau, and H. Li SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models Thromb. Res. 99 2000 587 594
63. W.D. Hill, D.C. Hess, and A. Martin-Studdard SDF-1 is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury J. Neuropathol. Exp. Neurol. 63 2004 84 96
64. J.D. van Buul, C. Voermans, and J. van Gelderen Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4 J. Biol. Chem. 278 2003 30302 30310
65. J. Yamaguchi, K.F. Kusano, and O. Masuo Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization Circulation 107 2003 1322 1328
66. T. Bourcier, T. Berbar, and S. Paquet Characterization and functionality of CXCR4 and SDF-1 in human corneal fibroblasts Mol. Vis. 9 2003 96 102
67. C. Hitchon, K. Wong, and G. Ma Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts Arthritis Rheum. 46 2002 2587 2597
68. T. Asahara, T. Takahashi, and H. Masuda VEGF contributes to postnatal neovascularization by mobilizing bone-marrow derived endothelial progenitor cells EMBO J. 18 1999 3964 3972
69. G. Schuch, J.V. Heymach, and M. Nomi Endostatin inhibits the VEGF-induced mobilization of endothelial progenitor cells Cancer Res. 63 2003 8345 8350
70. M. De Palma, M.A. Venneri, and C. Roca Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells Nat. Med. 9 2003 789 795
71. Y.H. Chen, H.L. Wu, and C.K. Chen Angiostatin antagonizes VEGF-A action in human endothelial cells via two distinct pathways Biochem. Biophys. Res. Comm. 310 2003 804 810
72. G. Thurston, C. Suri, and K. Smith Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 Science 286 1999 2511 2514
73. C. Cursiefen, C. Hofmann-Rummelt, and M. Kuchle Pericyte recruitment in corneal angiogenesis: an ultrastructural study with clinicopathological correlation Br. J. Ophthalmol. 87 2003 101 106